Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor
Previous Article
IC... 02T eugaeL sdnegeL -etadpU yru
Next Article
‘The... seitic gniretlews s’aidnI ni e